glp-1 7-37 Glucagon-like peptide 1 (1-37) Designing GLP-1 delivery: structural perspectives

Wayne Winegarden warns that unauthorized compounded GLP-1s are creating serious patient safety risks

This wildly popular drug is a synthetic form of GLP-1 (glucagon-like peptide-1), a hormone that regulates blood sugar and curbs appetite

in patients with knee osteoarthritis and type 2 diabetes if treatment is sustained for a sufficient period, according to data.The researchers, who published their findings in the Annals of the Rheumatic Diseases, added that the result may be mediated by weight loss.

Perfect For: - Current semaglutide/tirzepatide users

Background The worldwide rise in overweight and obesity is paralleled by an increasing prevalence of type-2 diabetes

One editor details her experience doing the F45 challenge for 8 weeks and gives her review of the program.